TAKE Solutions Announces Global Release of PharmaReady 5.0
TAKE Solutions Ltd.
announced the availability of PharmaReadyTM 5.0, a web-based regulatory compliance solution suite for Life Science organizations to ensure faster approvals for their new products. The latest version introduces new document management features, and delivers technology framework upgrades to enhance scalability, response time, and ease-of-use.
PharmaReady 5.0 supports submissions to Swissmedic (in addition to US FDA, Health Canada and EMEA). It comes with an improved dashboard for easier navigation and management of documents from a centralized location, provides more visibility and control of e-document/e-submission processes, and introduces new functionalities including drag and drop for quicker document uploads. In addition, PharmaReady 5.0 includes an enhanced, highly scalable technology framework allowing the suite to run seamlessly on any Microsoft platform.
Speaking on the occasion, Ram Yeleswarapu, President and CEO, TAKE Solutions, said, “TAKE Solutions has understood the pulse of the life sciences market and has worked persistently towards achieving the goal of better value to our customers. Having used both our IT expertise, as well as our domain knowledge, we are proud to release the upgraded version PharmaReady 5.0” He added, “PharmaReady is a stable and growing product line that has been consistently delivering value to our customers across the globe.”
“TAKE is committed to diligently listening to our customers as well as regulators, partners, and competitors,” stated Mike Lewis, Vice President –Life Sciences, TAKE Solutions. “This release is a key milestone marking our continuous efforts to add value and bring significant and relevant global regulatory standards to our life sciences customer base by acting as a key liaison, thought-leader, and solution provider in this space.”
The PharmaReady solution suite is designed specifically for management of SOPs,work instructions, training records, document and submission publishing in the eCTD and other formats, as well as to manage other electronic documents. PharmaReady is in full compliance with global regulatory requirements and was designed to be an easy to use, easy to deploy, and affordable solution.
PharmaReady has a record of 100% submission acceptance by regulatory authorities, and this is attributed to four key factors: comprehensive solution that meets the latest requirements, out-of-the-box implementation with minimum start-up time, compliance enabled, and a top-notch support team.
Pharmaready has a no. of global customers including Pharmaceutical, Medical device Companies, and CROs. A majority of regulatory submissions by Indian Pharma manufacturers are done using Pharmaready products or related services from TAKE.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
